Literature DB >> 26976860

Rapid Whole-Cell Assay of Antitubercular Drugs Using Second-Generation Fluoromycobacteriophages.

Estefanía Urdániz1, Liliana Rondón1, Marcelo A Martí1, Graham F Hatfull2, Mariana Piuri3.   

Abstract

Mesh：

Substances：

Year:  2016        PMID： 26976860      PMCID： PMC4862496          DOI： 10.1128/AAC.03016-15

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


× No keyword cloud information.
  18 in total

1.  φ(2)GFP10, a high-intensity fluorophage, enables detection and rapid drug susceptibility testing of Mycobacterium tuberculosis directly from sputum samples.

Authors:  Paras Jain; Travis E Hartman; Nell Eisenberg; Max R O'Donnell; Jordan Kriakov; Karnishree Govender; Mantha Makume; David S Thaler; Graham F Hatfull; A Willem Sturm; Michelle H Larsen; Preshnie Moodley; William R Jacobs
Journal:  J Clin Microbiol       Date:  2012-01-25       Impact factor: 5.948

2.  Evaluation of fluoromycobacteriophages for detecting drug resistance in Mycobacterium tuberculosis.

Authors:  Liliana Rondón; Mariana Piuri; William R Jacobs; Jacobus de Waard; Graham F Hatfull; Howard E Takiff
Journal:  J Clin Microbiol       Date:  2011-02-23       Impact factor: 5.948

Review 3.  The future for early-stage tuberculosis drug discovery.

Authors:  Edison S Zuniga; Julie Early; Tanya Parish
Journal:  Future Microbiol       Date:  2015       Impact factor: 3.165

4.  Rapid screening of natural products for antimycobacterial activity by using luciferase-expressing strains of Mycobacterium bovis BCG and Mycobacterium intracellulare.

Authors:  R M Shawar; D J Humble; J M Van Dalfsen; C K Stover; M J Hickey; S Steele; L A Mitscher; W Baker
Journal:  Antimicrob Agents Chemother       Date:  1997-03       Impact factor: 5.191

Review 5.  Tuberculosis treatment and drug regimens.

Authors:  Giovanni Sotgiu; Rosella Centis; Lia D'ambrosio; Giovanni Battista Migliori
Journal:  Cold Spring Harb Perspect Med       Date:  2015-01-08       Impact factor: 6.915

Review 6.  Tuberculosis treatment and management--an update on treatment regimens, trials, new drugs, and adjunct therapies.

Authors:  Alimuddin Zumla; Jeremiah Chakaya; Rosella Centis; Lia D'Ambrosio; Peter Mwaba; Matthew Bates; Nathan Kapata; Thomas Nyirenda; Duncan Chanda; Sayoki Mfinanga; Michael Hoelscher; Markus Maeurer; Giovanni Battista Migliori
Journal:  Lancet Respir Med       Date:  2015-03-09       Impact factor: 30.700

7.  Green fluorescent protein reporter microplate assay for high-throughput screening of compounds against Mycobacterium tuberculosis.

Authors:  L A Collins; M N Torrero; S G Franzblau
Journal:  Antimicrob Agents Chemother       Date:  1998-02       Impact factor: 5.191

Review 8.  Comprehensive analysis of methods used for the evaluation of compounds against Mycobacterium tuberculosis.

Authors:  Scott G Franzblau; Mary Ann DeGroote; Sang Hyun Cho; Koen Andries; Eric Nuermberger; Ian M Orme; Khisimuzi Mdluli; Iñigo Angulo-Barturen; Thomas Dick; Veronique Dartois; Anne J Lenaerts
Journal:  Tuberculosis (Edinb)       Date:  2012-08-30       Impact factor: 3.131

9.  A dual read-out assay to evaluate the potency of compounds active against Mycobacterium tuberculosis.

Authors:  Juliane Ollinger; Mai Ann Bailey; Garrett C Moraski; Allen Casey; Stephanie Florio; Torey Alling; Marvin J Miller; Tanya Parish
Journal:  PLoS One       Date:  2013-04-04       Impact factor: 3.240

10.  Fluoromycobacteriophages for rapid, specific, and sensitive antibiotic susceptibility testing of Mycobacterium tuberculosis.

Authors:  Mariana Piuri; William R Jacobs; Graham F Hatfull
Journal:  PLoS One       Date:  2009-03-20       Impact factor: 3.240
View more
  4 in total

Review 1.  The Use of Bacteriophages in Biotechnology and Recent Insights into Proteomics.

Authors:  Ana G Abril; Mónica Carrera; Vicente Notario; Ángeles Sánchez-Pérez; Tomás G Villa
Journal:  Antibiotics (Basel)       Date:  2022-05-13

2.  Dual-Reporter Mycobacteriophages (Φ2DRMs) Reveal Preexisting Mycobacterium tuberculosis Persistent Cells in Human Sputum.

Authors:  Paras Jain; Brian C Weinrick; Eric J Kalivoda; Hui Yang; Vanisha Munsamy; Catherine Vilcheze; Torin R Weisbrod; Michelle H Larsen; Max R O'Donnell; Alexander Pym; William R Jacobs
Journal:  mBio       Date:  2016-10-25       Impact factor: 7.867

3.  Fluoromycobacteriophages Can Detect Viable Mycobacterium tuberculosis and Determine Phenotypic Rifampicin Resistance in 3-5 Days From Sputum Collection.

Authors:  Liliana Rondón; Estefanía Urdániz; Cecilia Latini; Florencia Payaslian; Mario Matteo; Ezequiel J Sosa; Darío F Do Porto; Adrian G Turjanski; Sergio Nemirovsky; Graham F Hatfull; Susana Poggi; Mariana Piuri
Journal:  Front Microbiol       Date:  2018-07-05       Impact factor: 5.640

Review 4.  Reporter Phage-Based Detection of Bacterial Pathogens: Design Guidelines and Recent Developments.

Authors:  Susanne Meile; Samuel Kilcher; Martin J Loessner; Matthew Dunne
Journal:  Viruses       Date:  2020-08-26       Impact factor: 5.048
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.